Thrivent Financial for Lutherans Has $61.09 Million Holdings in Stevanato Group S.p.A. $STVN

by · The Markets Daily

Thrivent Financial for Lutherans grew its stake in Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 7.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,372,390 shares of the company’s stock after purchasing an additional 156,733 shares during the period. Thrivent Financial for Lutherans owned about 0.78% of Stevanato Group worth $61,089,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in STVN. Artisan Partners Limited Partnership grew its position in Stevanato Group by 20.0% during the second quarter. Artisan Partners Limited Partnership now owns 2,733,782 shares of the company’s stock worth $66,786,000 after buying an additional 455,323 shares in the last quarter. Bamco Inc. NY lifted its position in shares of Stevanato Group by 2.1% in the 2nd quarter. Bamco Inc. NY now owns 1,888,050 shares of the company’s stock worth $46,125,000 after acquiring an additional 39,528 shares during the period. Ranger Investment Management L.P. grew its holdings in shares of Stevanato Group by 125.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company’s stock worth $32,273,000 after purchasing an additional 735,417 shares in the last quarter. Champlain Investment Partners LLC increased its position in shares of Stevanato Group by 68.7% during the second quarter. Champlain Investment Partners LLC now owns 1,300,799 shares of the company’s stock valued at $31,779,000 after purchasing an additional 529,950 shares during the period. Finally, Pembroke Management LTD raised its stake in shares of Stevanato Group by 11.9% in the third quarter. Pembroke Management LTD now owns 1,283,216 shares of the company’s stock valued at $33,043,000 after purchasing an additional 136,710 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Stevanato Group in a research note on Monday, December 29th. Wall Street Zen raised shares of Stevanato Group from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Finally, Morgan Stanley began coverage on Stevanato Group in a report on Monday, December 1st. They set an “equal weight” rating and a $24.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Stevanato Group presently has an average rating of “Moderate Buy”.

Read Our Latest Stock Analysis on STVN

Stevanato Group Stock Performance

NYSE STVN opened at €15.73 on Monday. Stevanato Group S.p.A. has a 1-year low of €15.28 and a 1-year high of €28.00. The company has a 50 day moving average of €20.64 and a 200-day moving average of €23.14. The company has a current ratio of 1.89, a quick ratio of 1.30 and a debt-to-equity ratio of 0.26. The firm has a market cap of $4.76 billion, a price-to-earnings ratio of 27.28, a PEG ratio of 1.28 and a beta of 0.58.

Stevanato Group Profile

(Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

Featured Stories